logo

Ultragenyx Pharmaceutical Inc (RARE)



Trade RARE now with
  Date
  Headline
9/18/2017 8:35:59 AM Ultragenyx Proposes To Acquire Dimension Therapeutics For $5.50/Shr
9/14/2017 6:46:02 AM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) 2018 Estimate To -5.96 From -5.88
9/14/2017 6:45:46 AM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) 4Q18 Estimate To -1.78 From -1.77
9/14/2017 6:45:34 AM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) 3Q18 Estimate To -1.78 From -0.42
9/14/2017 6:45:13 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 2Q18 Estimate To -0.52 From -1.84
9/14/2017 6:44:06 AM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) 2018 Rev. Estimate To 93.0 M From 97.1 M
9/14/2017 6:43:49 AM Wedbush Is Cutting Ultragenyx Pharmaceutical Inc (RARE) 4Q18 Rev. Estimate To 14.6 M From 15.6 M
9/14/2017 6:43:35 AM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) 3Q18 Rev. Estimate To 11.5 M From 74.7 M
9/14/2017 6:43:18 AM Wedbush Is Increasing Ultragenyx Pharmaceutical Inc (RARE) 2Q18 Rev. Estimate To 65.9 M From 5.6 M
9/14/2017 6:42:44 AM Wedbush Is Lowering Ultragenyx Pharmaceutical Inc (RARE) 1Q18 Rev. Estimate To 1.0 M From 1.1 M
9/14/2017 6:40:57 AM Wedbush Raises Ultragenyx Pharmaceutical Inc (RARE) To Outperform From Neutral With $62 Price Target
8/24/2017 8:33:43 AM Ultragenyx And Kyowa Hakko Kirin Announce Submission Of Burosumab’s Biologics License Application In The US
8/24/2017 8:33:25 AM Ultragenyx Announces Burosumab Data Presentations At ASBMR 2017 Annual Meeting
8/23/2017 7:41:21 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 2018 Estimate To -5.88 From -6.00
8/23/2017 7:41:09 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 4Q18 Estimate To -1.77 From -1.79
8/23/2017 7:40:54 AM Wedbush Is Raising Ultragenyx Pharmaceutical Inc (RARE) 3Q18 Estimate To -0.42 From -0.43